720 related articles for article (PubMed ID: 11535926)
1. Intestinal protection by lafutidine, a histamine H(2)-receptor antagonist, against indomethacin-induced damage in rats--role of endogenous nitric oxide.
Tanaka A; Mizoguchi H; Hase S; Miyazawa T; Takeuchi K
Med Sci Monit; 2001; 7(5):869-77. PubMed ID: 11535926
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of lafutidine, a histamine H2 receptor antagonist, against loxoprofen-induced small intestinal lesions in rats.
Amagase K; Ochi A; Sugihara T; Kato S; Takeuchi K
J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S111-8. PubMed ID: 20586851
[TBL] [Abstract][Full Text] [Related]
3. Dual action of nitric oxide in pathogenesis of indomethacin-induced small intestinal ulceration in rats.
Tanaka A; Kunikata T; Mizoguchi H; Kato S; Takeuchi K
J Physiol Pharmacol; 1999 Sep; 50(3):405-17. PubMed ID: 10574470
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of lafutidine against indomethacin-induced intestinal ulceration in rats: relation to capsaicin-sensitive sensory neurons.
Kato S; Tanaka A; Kunikata T; Umeda M; Takeuchi K
Digestion; 2000; 61(1):39-46. PubMed ID: 10671773
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of roxatidine against indomethacin-induced small intestinal mucosal injury in rats.
Umegaki E; Yoda Y; Tokioka S; Murano M; Higuchi K
J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S35-40. PubMed ID: 20586863
[TBL] [Abstract][Full Text] [Related]
6. Induction of small intestinal damage in rats following combined treatment with cyclooxygenase-2 and nitric-oxide synthase inhibitors.
Ohno R; Yokota A; Tanaka A; Takeuchi K
J Pharmacol Exp Ther; 2004 Aug; 310(2):821-7. PubMed ID: 15044560
[TBL] [Abstract][Full Text] [Related]
7. Exacerbation of nonsteroidal anti-inflammatory drug-induced small intestinal lesions by antisecretory drugs in rats: the role of intestinal motility.
Satoh H; Amagase K; Takeuchi K
J Pharmacol Exp Ther; 2012 Nov; 343(2):270-7. PubMed ID: 22854201
[TBL] [Abstract][Full Text] [Related]
8. Gastro-protective action of lafutidine mediated by capsaicin-sensitive afferent neurons without interaction with TRPV1 and involvement of endogenous prostaglandins.
Fukushima K; Aoi Y; Kato S; Takeuchi K
World J Gastroenterol; 2006 May; 12(19):3031-7. PubMed ID: 16718783
[TBL] [Abstract][Full Text] [Related]
9. Protection by constitutively formed nitric oxide of intestinal damage induced by indomethacin in rats.
Tanaka A; Mizoguchi H; Kunikata T; Miyazawa T; Takeuchi K
J Physiol Paris; 2001; 95(1-6):35-41. PubMed ID: 11595416
[TBL] [Abstract][Full Text] [Related]
10. Role of endogenous nitric oxide (NO) and NO synthases in healing of indomethacin-induced intestinal ulcers in rats.
Takeuchi K; Hatazawa R; Tanigami M; Tanaka A; Ohno R; Yokota A
Life Sci; 2007 Jan; 80(4):329-36. PubMed ID: 17045617
[TBL] [Abstract][Full Text] [Related]
11. Effect of lafutidine, a novel histamine H2-receptor antagonist, on monochloramine-induced gastric lesions in rats: role of capsaicin-sensitive sensory neurons.
Umeda M; Fujita A; Nishiwaki H; Takeuchi K
J Gastroenterol Hepatol; 1999 Sep; 14(9):859-65. PubMed ID: 10535466
[TBL] [Abstract][Full Text] [Related]
12. Effect of NG-nitro-L-arginine methyl ester, the nitric oxide synthase inhibitor, on duodenal alkaline secretion and mepirizole-induced duodenal lesions in rats.
Takeuchi K; Takehara K; Kato S
J Clin Gastroenterol; 1995; 21 Suppl 1():S66-72. PubMed ID: 8774993
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide, superoxide radicals and mast cells in pathogenesis of indomethacin-induced small intestinal lesions in rats.
Konaka A; Nishijima M; Tanaka A; Kunikata T; Kato S; Takeuchi K
J Physiol Pharmacol; 1999 Mar; 50(1):25-38. PubMed ID: 10210152
[TBL] [Abstract][Full Text] [Related]
14. Roles of enterobacteria, nitric oxide and neutrophil in pathogenesis of indomethacin-induced small intestinal lesions in rats.
Konaka A; Kato S; Tanaka A; Kunikata T; Korolkiewicz R; Takeuchi K
Pharmacol Res; 1999 Dec; 40(6):517-24. PubMed ID: 10660951
[TBL] [Abstract][Full Text] [Related]
15. Lafutidine, a unique histamine H2-receptor antagonist, inhibits distention-induced gastric acid secretion through an H2 receptor-independent mechanism.
Nakano M; Kitano S; Nanri M; Kiniwa M
Eur J Pharmacol; 2011 May; 658(2-3):236-41. PubMed ID: 21349265
[TBL] [Abstract][Full Text] [Related]
16. Dopamine-induced protection against indomethacin-evoked intestinal lesions in rats--role of anti-intestinal motility mediated by D2 receptors.
Miyazawa T; Matsumoto M; Kato S; Takeuchi K
Med Sci Monit; 2003 Feb; 9(2):BR71-7. PubMed ID: 12601282
[TBL] [Abstract][Full Text] [Related]
17. Role of prostaglandins and nitric oxide in the lipopolysaccharide-induced ACTH and corticosterone response.
Gadek-Michalska A; Bugajski J
J Physiol Pharmacol; 2004 Sep; 55(3):663-75. PubMed ID: 15381835
[TBL] [Abstract][Full Text] [Related]
18. A histamine H2 receptor antagonist, roxatidine, stimulates mucus secretion and synthesis by cultured rabbit gastric mucosal cells.
Takahashi S; Okabe S
J Physiol Pharmacol; 1995 Dec; 46(4):503-11. PubMed ID: 8770793
[TBL] [Abstract][Full Text] [Related]
19. Investigation on the mechanisms involved in the central protective effect of amylin on gastric ulcers in rats.
Guidobono F; Pagani F; Ticozzi C; Sibilia V; Netti C
Br J Pharmacol; 1998 Sep; 125(1):23-8. PubMed ID: 9776339
[TBL] [Abstract][Full Text] [Related]
20. Stimulation by nitric oxide synthase inhibitors of gastric and duodenal HCO3- secretion in rats.
Takeuchi K; Ohuchi T; Miyake H; Okabe S
J Pharmacol Exp Ther; 1993 Sep; 266(3):1512-9. PubMed ID: 7690403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
